skip to content
Primary navigation


DrugOralair® (anthoxanthum odoratum pollen, dactylis glomerata pollen, lolium perenne pollen, phleum pratense pollen, and poa pratensis pollen) [Stallergenes S.A.]

April 2015

Therapeutic area - Allergy therapy

Approval criteria

  • Patient must be 10 years old or older AND
  • Patient has had a skin test positive to any of the 5 grass species in the product AND
  • Patient has tried and failed at least one drug out of 2 of the 3 following classes in the last 730 days: intranasal corticosteroids, oral antihistamines, leukotriene receptor antagonists OR
  • Patient has tried allergen-specific immunotherapy injections in the last 730 days

Quantity limit

300 IR: 34 tablets per 34 days


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top